GlassScriptPhysician profile
Jillian Cabai
NPI 1902269301
$6,632.69
in general payments reported to CMS, 2019-2025
28 companies · $642 in 2025
The $642 reported for 2025 was more than what 78% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $900 · 2020: $295 · 2021: $3,221 · 2022: $650 · 2023: $440 · 2024: $484 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,566.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $2,449.16 | 2021 | |
| Smith+Nephew, INC. | $1,782.72 | 2019-2025 | Grafix Pl, Grafix, Collagenase Santyl |
| Stryker Corporation | $583.61 | 2019-2025 | Augment Injectable, Prostep, Ortholoc 2 Lapifuse |
| Kerecis Limited | $221.31 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Medical Device Business Services, INC. | $209.99 | 2019 | |
| Organogenesis INC. | $151.41 | 2021-2022 | |
| Medline Industries LP | $124.64 | 2022-2025 | |
| Novastep INC. | $118.05 | 2021 | |
| Pylant Medical | $109.09 | 2019 | |
| Orthofix Medical, INC. | $100.49 | 2020-2025 | Physio-Stim |
| Bioventus LLC | $97.18 | 2021-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $88.31 | 2019-2023 | Krystexxa |
| Amgen INC. | $64.81 | 2025 | Krystexxa |
| Nevro Corp. | $56.91 | 2022-2023 | Senza |
| Abbott Laboratories | $46.14 | 2023 | Proclaim, Eterna |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $43.52 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Polynovo North America LLC | $42.43 | 2022-2025 | Novosorb Btm |
| Urgo Medical North America, LLC | $37.20 | 2025 | Urgok2 |
| Acera Surgical, INC. | $37.04 | 2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $36.49 | 2025 | Minibunion |
| Treace Medical Concepts, INC. | $35.20 | 2024 | |
| Paragon 28, INC. | $35.07 | 2025 | Tenotac |
| Encore Medical, LP | $31.01 | 2022 | |
| Kci USA, INC. | $29.16 | 2023 | V.A.C. Dermatac |
| Zimmer Biomet Holdings, INC. | $29.11 | 2019 | |
| Lightbody Medical Technologies INC | $29.03 | 2024 | |
| Mimedx Group, INC. | $22.24 | 2025 | |
| Aroa Biosurgery Incorporated | $21.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Cabai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.